Finance

Lists
AVTR:NYSE
Avantor Inc
$15.14
-1.37%
(-0.21) 1D
Oct 8, 11:00:41 AM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVTR...
Open
$15.22
High
$15.30
Low
$14.96
Mkt. cap
10.24B
Avg. vol.
8.40M
Volume
984.21K
52-wk high
$16.38
52-wk low
$7.26
EPS
-$0.85
Beta
0.94
Shares outstanding
676.36M
No. of employees
14K
Open
$15.22
High
$15.30
Low
$14.96
Mkt. cap
10.24B
Avg. vol.
8.40M
Volume
984.21K
52-wk high
$16.38
52-wk low
$7.26
EPS
-$0.85
Beta
0.94
Shares outstanding
676.36M
No. of employees
14K
News stories
From web sources and news partners
Profile
Avantor, Inc. is an American biotechnology, chemicals, and pharmaceutical company headquartered in Radnor, Pennsylvania. Established in 1904 as J.T. Baker, the company changed its name to Avantor in 2010. Avantor went public in 2019 and is now listed on the New York Stock Exchange under the symbol “AVTR”. Wikipedia
About Avantor Inc
CEOEmmanuel Ligner
Employees13.5K
Founded1904
HeadquartersRadnor Township, Pennsylvania, United States
SectorHealth care
Websiteavantorsciences.com
Analyst ratings
Based on 12 analysts giving stock ratings to AVTR in the past 3 months
Hold
Buy
0
Hold
11
Sell
1
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for AVTR in the last 3 months.
Highest
Current $15.14
$16.00 (+5.72%)
Average
$14.23 (-5.98%)
Lowest
$12.00 (-20.71%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luke Sergott
Barclays
Sell
Maintained
$15.00
-0.9%
10/07/2026
Eve Burstein
Bernstein
Hold
Maintained
$15.50
+2.4%
09/25/2026
Evan Stampler
Wells Fargo
Buy
Maintained
$16.00
+5.7%
09/21/2026
Matt Larew
William Blair
Hold
Reiterated
-
-
09/21/2026
Unknown Analyst
UBS
Hold
Initiated
$16.00
+5.7%
09/08/2026
Doug Schenkel
UBS
Hold
Maintained
$16.00
+5.7%
09/09/2026
Casey Woodring
J.P. Morgan
Hold
Reiterated
$12.00
-20.7%
07/30/2026
Vijay Kumar
Evercore ISI
Hold
Maintained
$14.00
-7.5%
07/30/2026
Justin Bowers
Deutsche Bank
Hold
Maintained
$13.00
-14.1%
07/30/2026
Daniel Arias
Stifel Nicolaus
Hold
Reiterated
$15.00
-0.9%
07/30/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
$16.00
+5.7%
07/30/2026
Dan Leonard
RBC Capital
Hold
Maintained
$14.00
-7.5%
07/29/2026
Tycho Peterson
Jefferies
Hold
Upgraded
$13.00
-14.1%
07/29/2026
Daniel Brennan
TD Cowen
Hold
Maintained
$15.00
-0.9%
07/29/2026
Kallum Titchmarsh
Morgan Stanley
Hold
Maintained
$14.00
-7.5%
07/30/2026
Patrick B Donnelly
Citi
Hold
Maintained
$11.00
-27.3%
07/08/2026
Michael Polark
Wolfe Research
Sell
Reiterated
$7.00
-53.7%
06/01/2026
Unknown Analyst
RBC Capital
Hold
Initiated
$9.00
-40.5%
05/14/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
$11.00
-27.3%
02/12/2026
Michael Ryskin
Bank of America Securities
Hold
Reiterated
$11.00
-27.3%
02/11/2026
Last report
Jul 29, 2026
Fiscal period
Q2 2026
$0.21 / $0.19
+11.09%beat
Revenue / Est. (USD)
1.69B / 1.61B
+5.27%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.62B
1.66B
1.58B
1.69B
Cost of goods sold
1.10B
1.14B
1.08B
1.16B
Cost of revenue
1.10B
1.14B
1.08B
1.16B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
388.80M
354.70M
401.70M
415.80M
Operating expense
388.80M
354.70M
401.70M
415.80M
Total operating expenses
1.49B
1.49B
1.48B
1.57B
Operating income
137.70M
169.20M
99.00M
121.20M
Other non operating income
700.00K
-7.00M
-
100.00K
EBT including unusual items
-689.50M
80.80M
55.50M
81.20M
EBT excluding unusual items
95.70M
120.10M
56.10M
81.80M
Income tax expense
22.30M
28.40M
12.20M
43.10M
Effective tax rate
-3.23%
35.15%
21.98%
53.08%
Other operating expenses
-
-
-
-
Net income
-711.80M
52.40M
43.30M
38.10M
Net profit margin
-43.84%
3.15%
2.74%
2.25%
Earnings per share
0.22
0.22
0.17
0.21
Interest and investment income
11.90M
11.40M
10.50M
10.30M
Interest expense
-58.00M
-53.40M
-53.40M
-49.70M
Net interest expenses
-46.10M
-42.00M
-42.90M
-39.40M
Depreciation and amortization charges
-
-
-
-
EBITDA
242.20M
272.50M
204.00M
226.80M
Gain or loss from assets sale
-
5.10M
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps